| For: | Baiz D, Dapas B, Farra R, Scaggiante B, Pozzato G, Zanconati F, Fiotti N, Consoloni L, Chiaretti S, Grassi G. Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines. World J Gastroenterol 2014; 20(3): 795-803 [PMID: 24574752 DOI: 10.3748/wjg.v20.i3.795] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i3/795.htm |
| Number | Citing Articles |
| 1 |
B. Dapas, S. Dall’Acqua, R. Bulla, C. Agostinis, B. Perissutti, S. Invernizzi, G. Grassi, D. Voinovich. Immunomodulation mediated by a herbal syrup containing a standardized Echinacea root extract: A pilot study in healthy human subjects on cytokine gene expression. Phytomedicine 2014; 21(11) doi: 10.1016/j.phymed.2014.04.034
|
| 2 |
Grażyna Świderska-Kołacz, Magdalena Madej, Szymon Zmorzynski, Wojciech Styk, Iwona Surowiec, Bożena Witek, Anna Wojciechowska, Joanna Czerwik-Marcinkowska, Anna Nowakowska. Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells. PeerJ 2025; 13 doi: 10.7717/peerj.19235
|
| 3 |
Mi Na Kim, Seung Min Lee, Jin Sung Kim, Seong Gyu Hwang. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 2019; 84(4) doi: 10.1007/s00280-019-03918-y
|
| 4 |
Alexander Krohannon, Mansi Srivastava, Neel Sangani, Sarath Chandra Janga. Regulation Ratio: A Singular Multi-Omic Measurement of Gene Regulatory Mechanisms. Computational and Structural Biotechnology Journal 2026; 35(1) doi: 10.34133/csbj.0044
|
| 5 |
Federica Tonon, Cristina Zennaro, Barbara Dapas, Michele Carraro, Massimo Mariotti, Gabriele Grassi. Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing. International Journal of Pharmaceutics 2016; 515(1-2) doi: 10.1016/j.ijpharm.2016.10.070
|
| 6 |
Andrea Feliciano, Yoelsis Garcia-Mayea, Luz Jubierre, Cristina Mir, Manuela Hummel, Josep Castellvi, Javier Hernández-Losa, Rosanna Paciucci, Irene Sansano, Yilin Sun, Santiago Ramón y Cajal, Hiroshi Kondon, Aroa Soriano, Miguel Segura, Alex Lyakhovich, Matilde E LLeonart. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer. Cell Death & Disease 2017; 8(10) doi: 10.1038/cddis.2017.544
|
| 7 |
Justin T. Huntington, Xing Tang, Lindsey N. Kent, Carl R. Schmidt, Gustavo Leone. The Spectrum of E2F in Liver Disease-Mediated Regulation in Biology and Cancer. Journal of Cellular Physiology 2016; 231(7) doi: 10.1002/jcp.25242
|
| 8 |
Rashmi Nagesh, Rajeshwari H. Patil, M. Naveen Kumar, K.M. Kiran Kumar, Shivaleela Biradar, Babu R. Lamani. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00014-4
|
| 9 |
Sheng-Sheng Zhou, Yu-Ping Ye, Yi Chen, Da-Tong Zeng, Guang-Cai Zheng, Rong-Quan He, Bang-Teng Chi, Lei Wang, Qian Lin, Qin-Yan Su, Yi-Wu Dang, Gang Chen, Jia-Liang Wei. Overexpression pattern, function, and clinical value of proteasome 26S subunit non-ATPase 6 in hepatocellular carcinoma. World Journal of Clinical Oncology 2025; 16(2): 99839 doi: 10.5306/wjco.v16.i2.99839
|
| 10 |
Margot S. F. Roeten, Jacqueline Cloos, Gerrit Jansen. Positioning of proteasome inhibitors in therapy of solid malignancies. Cancer Chemotherapy and Pharmacology 2018; 81(2) doi: 10.1007/s00280-017-3489-0
|
| 11 |
Zhiwei Bian, Menny M. Benjamin, Lucas Bialousow, Yintai Tian, G. Aaron Hobbs, Dev Karan, Yeun-Mun Choo, Mark T. Hamann, Xiaojuan Wang. Targeting sine oculis homeoprotein 1 (SIX1): A review of oncogenic roles and potential natural product therapeutics. Heliyon 2024; 10(12) doi: 10.1016/j.heliyon.2024.e33204
|
| 12 |
Gennara Cavallaro, Rossella Farra, Emanuela Fabiola Craparo, Carla Sardo, Barbara Porsio, Gaetano Giammona, Francesca Perrone, Mario Grassi, Gabriele Pozzato, Gabriele Grassi, Barbara Dapas. Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells. International Journal of Pharmaceutics 2017; 525(2) doi: 10.1016/j.ijpharm.2017.01.034
|
| 13 |
Rossella Farra, Bruna Scaggiante, Chiara Guerra, Gabriele Pozzato, Mario Grassi, Fabrizio Zanconati, Francesca Perrone, Cinzia Ferrari, Francesco Trotta, Gabriele Grassi, Barbara Dapas. Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs. International Journal of Pharmaceutics 2017; 525(2) doi: 10.1016/j.ijpharm.2017.02.031
|
| 14 |
Tian-Hao Li, Cheng Qin, Bang-Bo Zhao, Hong-Tao Cao, Xiao-Ying Yang, Yuan-Yang Wang, Ze-Ru Li, Xing-Tong Zhou, Wei-Bin Wang. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.665192
|
| 15 |
I-Tao Huang, Bijay Dhungel, Ritu Shrestha, Kim R. Bridle, Darrell H. G. Crawford, Aparna Jayachandran, Jason C Steel. Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma. Expert Opinion on Investigational Drugs 2019; 28(1) doi: 10.1080/13543784.2019.1551359
|
| 16 |
Pihong Li, Xiaoyu Pan, Zhouci Zheng, Yihan Sun, Yifan Han, Jianda Dong. LINC00271 inhibits epithelial-mesenchymal transition of papillary thyroid cancer cells by downregulating trefoil factor 3 expression. Aging Pathobiology and Therapeutics 2020; 2(2) doi: 10.31491/APT.2020.06.018
|
| 17 |
Shirley Jusino, Harold I Saavedra. Role of E2Fs and mitotic regulators controlled by E2Fs in the epithelial to mesenchymal transition. Experimental Biology and Medicine 2019; 244(16) doi: 10.1177/1535370219881360
|
| 18 |
Ying Lü, Jing Zhang, Lei Li, Shun Li, Zongguo Yang. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report. Bioscience Reports 2020; 40(2) doi: 10.1042/BSR20193212
|
| 19 |
N. Halib, M.C.I. Mohd Amin, I. Ahmad, M. Abrami, S. Fiorentino, R. Farra, G. Grassi, F. Musiani, R. Lapasin, M. Grassi. Topological characterization of a bacterial cellulose–acrylic acid polymeric matrix. European Journal of Pharmaceutical Sciences 2014; 62 doi: 10.1016/j.ejps.2014.06.004
|
| 20 |
Rossella Farra, Barbara Dapas, Daniele Baiz, Federica Tonon, Sara Chiaretti, Giannino Del Sal, Alessandra Rustighi, Nicola Elvassore, Gabriele Pozzato, Mario Grassi, Gabriele Grassi. Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells. Biochimie 2015; 112 doi: 10.1016/j.biochi.2015.02.015
|
| 21 |
Bruna Scaggiante, Rosella Farra, Barbara Dapas, Gabriele Baj, Gabriele Pozzato, Mario Grassi, Fabrizio Zanconati, Gabriele Grassi. Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects. International Journal of Pharmaceutics 2016; 506(1-2) doi: 10.1016/j.ijpharm.2016.04.031
|
| 22 |
Federica Tonon, Rossella Farra, Cristina Zennaro, Gabriele Pozzato, Nhung Truong, Salvatore Parisi, Flavio Rizzolio, Mario Grassi, Bruna Scaggiante, Fabrizio Zanconati, Deborah Bonazza, Gabriele Grassi, Barbara Dapas. Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules. Pharmaceuticals 2021; 14(8) doi: 10.3390/ph14080803
|
| 23 |
Emre Cebeci, Büşra Yüksel, Fikrettin Şahin. Anti-cancer effects of boron derivatives on non-small cell lung cancer. Journal of Trace Elements in Medicine and Biology 2025; 88 doi: 10.1016/j.jtemb.2025.127627
|
| 24 |
C. Sardo, R. Farra, M. Licciardi, B. Dapas, C. Scialabba, G. Giammona, M. Grassi, G. Grassi, G. Cavallaro. Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system. European Journal of Pharmaceutical Sciences 2015; 75 doi: 10.1016/j.ejps.2015.03.021
|
| 25 |
Yi Xie, Jing Si, Yu‐Pei Wang, Hong‐Yan Li, Cui‐Xia Di, Jun‐Fang Yan, Yan‐Cheng Ye, Yan‐Shan Zhang, Hong Zhang. E2F is involved in radioresistance of carbon ion induced apoptosis via Bax/caspase 3 signal pathway in human hepatoma cell. Journal of Cellular Physiology 2018; 233(2) doi: 10.1002/jcp.26005
|
| 26 |
Jingcheng Wang, Yang Tian, Hui Chen, Hui Li, Shusen Zheng. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8871
|
| 27 |
G. Cavallaro, M. Licciardi, G. Amato, C. Sardo, G. Giammona, R. Farra, B. Dapas, M. Grassi, G. Grassi. Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery. International Journal of Pharmaceutics 2014; 466(1-2) doi: 10.1016/j.ijpharm.2014.03.026
|
| 28 |
Yan-Jie Chen, Hao Wu, Xi-Zhong Shen. The ubiquitin–proteasome system and its potential application in hepatocellular carcinoma therapy. Cancer Letters 2016; 379(2) doi: 10.1016/j.canlet.2015.06.023
|
| 29 |
Marianna Maddaloni, Rossella Farra, Barbara Dapas, Fulvia Felluga, Fabio Benedetti, Federico Berti, Sara Drioli, Mattia Vidali, Maja Cemazar, Urska Kamensek, Claudio Brancolini, Erminio Murano, Francesca Maremonti, Mario Grassi, Alice Biasin, Flavio Rizzolio, Enrico Cavarzerani, Bruna Scaggiante, Roberta Bulla, Andrea Balduit, Giuseppe Ricci, Gabriella Zito, Federico Romano, Serena Bonin, Eros Azzalini, Gabriele Baj, Domenico Tierno, Gabriele Grassi. In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells. Pharmaceutics 2024; 16(5) doi: 10.3390/pharmaceutics16050664
|
| 30 |
Shouping Wang, Kun Cao, Yuting Liao, Wei Zhang, Jihua Zheng, Xiaocui Li, Mengting Huang, Yonghao Zhong, Xiao Hu, De Chen, Yanjie Wang. CDCA2 protects against oxidative stress by promoting BRCA1–NRF2 signaling in hepatocellular carcinoma. Oncogene 2021; 40(25) doi: 10.1038/s41388-021-01855-w
|